GlassScriptPhysician profile
Annie J Steen
NPI 1962759464
$824.40
in general payments reported to CMS, 2019-2025
22 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $212 · 2023: $266 · 2024: $96.57 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $494 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.13 |
| Education | $117.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $194.31 | 2023-2025 | Darzalex, Tecvayli, Talvey |
| Seagen INC. | $118.80 | 2022-2023 | Adcetris |
| Daiichi Sankyo INC. | $58.51 | 2023-2025 | Enhertu, Injectafer |
| Pharmacosmos Therapeutics INC. | $48.38 | 2023 | Monoferric |
| Eisai INC. | $45.76 | 2022-2024 | |
| Aveo Pharmaceuticals, INC. | $40.00 | 2025 | |
| Amgen INC. | $35.86 | 2023-2025 | Imdelltra (Amg757), Kyprolis, Blincyto |
| Pharmaessentia USA Corporation | $29.12 | 2022-2023 | Besremi |
| Abbvie INC. | $23.38 | 2024 | |
| Genentech USA, INC. | $22.44 | 2022 | |
| Rigel Pharmaceuticals, INC. | $21.52 | 2022 | |
| Pfizer INC. | $20.87 | 2025 | |
| Tersera Therapeutics LLC | $20.67 | 2023 | Xermelo |
| Array Biopharma INC | $19.48 | 2025 | Xalkori, Braftovi, Lorbrena |
| Servier Pharmaceuticals LLC | $18.60 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $17.59 | 2023 | Reblozyl |
| Agios Pharmaceuticals, INC. | $16.92 | 2023 | |
| Beigene USA, INC. | $16.25 | 2022 | |
| Puma Biotechnology, INC. | $16.04 | 2024 | |
| Kite Pharma, INC. | $14.73 | 2023 | |
| Eusa Pharma (US) LLC | $13.39 | 2022 | |
| Astellas Pharma US INC | $11.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annie Steen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.